Zhejiang Medicine Co.,Ltd.(600216),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

600216 Zhejiang Medicine Co.,Ltd.

Closed 12-12 15:00:00

13.86

+0.02

+0.14%

High13.90	Low13.78	Vol6.58M
Open13.83	D1 Closing13.84	Amplitude0.87%
Mkt Cap13.33B	Tradable Cap13.33B	Total Shares962.00M
T/O91.10M	T/O Rate0.68%	Tradable Shares962.00M
P/B1.21	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"600216","market":"SH","secType":"STK","nameCN":"Zhejiang Medicine Co.,Ltd.","latestPrice":13.86,"timestamp":1765522800000,"preClose":13.84,"halted":0,"volume":6577456,"delay":0,"changeRate":0.0014,"floatShares":961999999,"shares":961999999,"eps":1.2937,"marketStatus":"Closed","change":0.02,"latestTime":"12-12 15:00:00","open":13.83,"high":13.9,"low":13.78,"amount":91104600,"amplitude":0.0087,"askPrice":13.87,"askSize":302,"bidPrice":13.86,"bidSize":7,"shortable":0,"etf":0,"ttmEps":1.2937,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1765762200000},"marketStatusCode":5,"adr":0,"adjPreClose":13.84,"symbolType":"stock","openAndCloseTimeList":[[1765503000000,1765510200000],[1765515600000,1765522800000]],"highLimit":15.22,"lowLimit":12.46,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":961637750,"isCdr":false,"pbRate":1.21,"roa":"--","peRate":10.713458,"roe":"8.49%","epsLYR":1.21,"committee":-0.106656,"marketValue":13328000000,"turnoverRate":0.0068,"status":0,"nextConnectDate":"Northbound have stopped. The next trading day is UTC+8 2025-12-15.","floatMarketCap":13328000000},"requestUrl":"/m/hq/s/600216/wiki","defaultTab":"wiki","newsList":[{"id":"2586321694","title":"Zhejiang Medicine Directors Approve Spin-off, Separate Hong Kong Listing of Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2586321694","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586321694?lang=en_us&edition=fundamental","pubTime":"2025-11-27 13:00","pubTimestamp":1764219642,"startTime":"0","endTime":"0","summary":"Zhejiang Medicine  directors approved the spin-off of subsidiary Zhejiang Xinma Biopharmaceutical and separate listing on the Hong Kong Stock Exchange, according to a Thursday filing with the Shanghai bourse.The spin-off is seen to widen Xinma's financing channels, optimize resource allocation, and help with its stable and sustainable development, the filing said.The proposed spin-off and listing will not result in a change of control over Xinma, the filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0188","BK0239","BK0028","BK0191","600216"],"gpt_icon":0},{"id":"1110403807","title":"Zhejiang Medicine (600216.SH) Plans to Spin Off Subsidiary Xinkang Biotech for HKEX Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=1110403807","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110403807?lang=en_us&edition=fundamental","pubTime":"2025-11-26 17:54","pubTimestamp":1764150854,"startTime":"0","endTime":"0","summary":"Zhejiang Medicine Co., Ltd. (600216.SH) announced plans to spin off its subsidiary, Zhejiang Xinkang Biopharmaceutical Co., Ltd. (\"Xinkang Biotech\"), for a potential listing on the Hong Kong Stock...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600216","BK0239","BK0188","BK0028","BK0191"],"gpt_icon":0},{"id":"2586237001","title":"Zhejiang Medicine  Says It Plans to Spin off Unit for Hong Kong Float","url":"https://stock-news.laohu8.com/highlight/detail?id=2586237001","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586237001?lang=en_us&edition=fundamental","pubTime":"2025-11-26 17:27","pubTimestamp":1764149247,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nL4N3X20OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["600216","BK0191","BK0028","BK0188","BK0239"],"gpt_icon":0},{"id":"2586230863","title":"BRIEF-Zhejiang Medicine To Spin Off Unit For Hong Kong Float","url":"https://stock-news.laohu8.com/highlight/detail?id=2586230863","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586230863?lang=en_us&edition=fundamental","pubTime":"2025-11-26 17:27","pubTimestamp":1764149247,"startTime":"0","endTime":"0","summary":"BRIEF-Zhejiang Medicine To Spin Off Unit For Hong Kong FloatNov 26 (Reuters) - Zhejiang Medicine Co Ltd 600216.SS:SAYS IT PLANS TO SPIN OFF UNIT FOR HONG KONG FLOATSource textFurther company coverage: 600216.SS (Reporting by Beijing Newsroom) ((Ethan.Wang@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nL4N3X20OU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0191","600216","BK0239","BK0028","BK0188"],"gpt_icon":0},{"id":"2578174906","title":"Zhejiang Medicine  Says Unit Plans to Invest 1.7 Bln Yuan in Biological Construction Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2578174906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578174906?lang=en_us&edition=fundamental","pubTime":"2025-10-27 18:55","pubTimestamp":1761562513,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL4N3W80S2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["600216","BK0028","BK0188","BK0239","BK0191"],"gpt_icon":0},{"id":"2578161741","title":"BRIEF-Zhejiang Medicine's Unit To Invest In Biological Construction Project","url":"https://stock-news.laohu8.com/highlight/detail?id=2578161741","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578161741?lang=en_us&edition=fundamental","pubTime":"2025-10-27 18:55","pubTimestamp":1761562513,"startTime":"0","endTime":"0","summary":"BRIEF-Zhejiang Medicine's Unit To Invest In Biological Construction ProjectOct 27  - Zhejiang Medicine Co Ltd 600216.SS:SAYS UNIT PLANS TO INVEST 1.7 BILLION YUAN  IN BIOLOGICAL CONSTRUCTION PROJECTSource textFurther company coverage: 600216.SS  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251027:nL4N3W80S2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0191","BK0028","600216","BK0188","BK0239"],"gpt_icon":0},{"id":"1188262290","title":"Zhejiang Medicine Co.,Ltd.: Vitamin E Oil is One of the Leading Products in Company's Life Nutrition Segment","url":"https://stock-news.laohu8.com/highlight/detail?id=1188262290","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188262290?lang=en_us&edition=fundamental","pubTime":"2025-09-26 21:11","pubTimestamp":1758892301,"startTime":"0","endTime":"0","summary":"Zhejiang Medicine Co.,Ltd. responded to investor inquiries on its interactive platform on September 26, stating that vitamin E oil is one of the leading products in the company's life nutrition segment. The company determines actual production volume according to market demand.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0188","600216","BK0191","BK0028","BK0239"],"gpt_icon":0},{"id":"1123362913","title":"Zhejiang Medicine Co.,Ltd. (600216.SH): Guotou High-tech Plans to Reduce Holdings by No More Than 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1123362913","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123362913?lang=en_us&edition=fundamental","pubTime":"2025-09-22 17:50","pubTimestamp":1758534637,"startTime":"0","endTime":"0","summary":"Zhejiang Medicine Co.,Ltd. (600216.SH) announced that Guotou High-tech, based on its operational development requirements, plans to reduce its shareholding through centralized competitive bidding...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0191","BK0028","600216","BK0188"],"gpt_icon":0},{"id":"1176728539","title":"Zhejiang Medicine Co.,Ltd. (600216.SH) Reports Semi-Annual Results with Net Profit of 673 Million Yuan, Up 113.52% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1176728539","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176728539?lang=en_us&edition=fundamental","pubTime":"2025-08-25 23:18","pubTimestamp":1756135117,"startTime":"0","endTime":"0","summary":"Zhejiang Medicine Co.,Ltd. (600216.SH) disclosed its 2025 semi-annual report. During the reporting period, the company achieved revenue of 4.323 billion yuan, down 1.87% year-on-year; net profit...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0188","BK0191","BK0028","600216"],"gpt_icon":0},{"id":"2562172322","title":"BRIEF-Zhejiang Medicine H1 Net Profit Up 113.5% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2562172322","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562172322?lang=en_us&edition=fundamental","pubTime":"2025-08-25 17:41","pubTimestamp":1756114886,"startTime":"0","endTime":"0","summary":"BRIEF-Zhejiang Medicine H1 Net Profit Up 113.5% Y/YAug 25 (Reuters) - Zhejiang Medicine Co Ltd 600216.SS:H1 NET PROFIT UP 113.5% Y/YSource textFurther company coverage: 600216.SS (Reporting by Beijing Newsroom) ((yukun.zhang@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL4N3UH0K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0191","BK0028","600216","BK0188","BK0239"],"gpt_icon":0},{"id":"2562121728","title":"Zhejiang Medicine  H1 Net Profit up 113.5% Y/Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2562121728","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562121728?lang=en_us&edition=fundamental","pubTime":"2025-08-25 17:41","pubTimestamp":1756114886,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250825:nL4N3UH0K3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0028","BK0191","BK0188","BK0239","600216"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"1999-10-21","address":"浙江省绍兴市越城区滨海新城致远中大道168号","stockEarnings":[{"period":"1week","weight":-0.0114},{"period":"1month","weight":-0.0741},{"period":"3month","weight":-0.0906},{"period":"6month","weight":-0.0864},{"period":"1year","weight":-0.161},{"period":"ytd","weight":-0.1049}],"companyName":"浙江医药股份有限公司","boardCode":"AI0027","perCapita":"15258股","boardName":"医药制造业","registeredCapital":"96163万元","compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0277},{"period":"3month","weight":0.0048},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1236},{"period":"ytd","weight":0.1604}],"survey":"　　浙江医药股份有限公司的主营业务是生命营养品、药品。公司的主要产品是合成维生素E、维生素A、天然维生素E、维生素H(生物素)、维生素D3、辅酶Q10、β-胡萝卜素、斑蝥黄素、叶黄素、番茄红素等维生素和类维生素产品、医药制造类产品及医药商业。报告期内，公司在CPHI2025荣获“LeadingEnterpriseofPharmaInternationalizationAwards”（医药国际化领军企业奖），在HHB健康美丽产业高质量发展大会被评为“健康美丽产业绿色可持续发展先锋企业”。","serverTime":1765722057400,"listedPrice":5.16,"stockholders":"63021人(较上一季度减少3.83%)","compareStock":{"symbol":"000001.SH","name":"SSE Comp"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Zhejiang Medicine Co.,Ltd.(600216),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Zhejiang Medicine Co.,Ltd.(600216) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Zhejiang Medicine Co.,Ltd.,600216,Zhejiang Medicine Co.,Ltd.股票,Zhejiang Medicine Co.,Ltd.股票老虎,Zhejiang Medicine Co.,Ltd.股票老虎国际,Zhejiang Medicine Co.,Ltd.行情,Zhejiang Medicine Co.,Ltd.股票行情,Zhejiang Medicine Co.,Ltd.股价,Zhejiang Medicine Co.,Ltd.股市,Zhejiang Medicine Co.,Ltd.股票价格,Zhejiang Medicine Co.,Ltd.股票交易,Zhejiang Medicine Co.,Ltd.股票购买,Zhejiang Medicine Co.,Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Zhejiang Medicine Co.,Ltd.(600216),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Zhejiang Medicine Co.,Ltd.(600216) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction